MD-PhD Human Genetics student, Mark Sorin has received the FRQS' Jacques-Genest Rising Star Award for his contributions towards paper published inÌýNature titled 'Single-cell spatial landscapes of the lung tumour immune microenvironment'. .
The following announcement is being sent on behalf of Dr. Vicky Tagalakis, Physician-in-Chief:
Ìý
Dear Colleagues,
Ìý
We are delighted to announce the appointment of Dr. William Foulkes as the Chief of the Division of Medical Genetics in the Jewish General Hospital Department of Medicine, effective January 1, 2024.
Ìý
Dr. Foulkes is a three-time graduate of the University of London, holding a BSc in Anatomy, a Bachelor of Medicine and Bachelor of Surgery, and a PhD in Molecular Genetics.
Ìý
​Please refer to theÌýHow to Apply for a Job (for External Candidates)Ìýjob aid for instructions on how to apply.
Established in 1993, ƽÌØÎå²»ÖÐ’s world-renowned Department of Human Genetics is celebrating its 30th anniversary. Join us for a walk down memory lane with past and present Chairs David Rosenblatt, Eric Shoubridge and William Foulkes.
![](/channels/files/channels/styles/medium/public/channels/image/french-canadians-photo4.jpg?itok=8EkITB6w)
Though we all share common ancestors ranging from a few generations to hundreds of thousands of years, genealogies that relate all of us are often forgotten over time. A is now providing insight into the complex relationship between human migration and genetic variation, using a unique genealogical dataset of over five million records spanning 400 years to unravel the genetic structure of French Canadian populations.
![](/channels/files/channels/styles/medium/public/channels/image/hospital-stay.jpg?itok=q-6tczG0)
First of humans with a rare immunodeficiency reveals how the immune system protects the body against pathogens known to cause serious diseases, such as tuberculosis and COVID-19. The research involving ƽÌØÎå²»ÖÐ, paves the way for new therapies to treat autoimmune diseases, chronic inflammatory diseases, and new approaches to vaccine development.
Ìý
Ìý
A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at ƽÌØÎå²»ÖÐ and the German Cancer Research Center.